214 related articles for article (PubMed ID: 34746322)
1. miR-126 in Extracellular Vesicles Derived from Hepatoblastoma Cells Promotes the Tumorigenesis of Hepatoblastoma through Inducing the Differentiation of BMSCs into Cancer Stem Cells.
Hu Y; Zai H; Jiang W; Yao Y; Ou Z; Zhu Q
J Immunol Res; 2021; 2021():6744715. PubMed ID: 34746322
[TBL] [Abstract][Full Text] [Related]
2. microRNA-148a-3p in extracellular vesicles derived from bone marrow mesenchymal stem cells suppresses SMURF1 to prevent osteonecrosis of femoral head.
Huang S; Li Y; Wu P; Xiao Y; Duan N; Quan J; Du W
J Cell Mol Med; 2020 Oct; 24(19):11512-11523. PubMed ID: 32871042
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis.
Liu X; Jiang F; Wang Z; Tang L; Zou B; Xu P; Yu T
J Cell Mol Med; 2021 Jan; 25(1):96-109. PubMed ID: 33219752
[TBL] [Abstract][Full Text] [Related]
4. Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p.
Deng L; Wang C; He C; Chen L
Cancer Biomark; 2021; 30(2):223-235. PubMed ID: 33136092
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-497-5p inhibit RSPO2 and accelerate OPLL.
Chen X; Wang S; Cui Z; Gu Y
Life Sci; 2021 Aug; 279():119481. PubMed ID: 33857573
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
7. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells.
Zhu T; Hu Z; Wang Z; Ding H; Li R; Wang J; Wang G
Cell Biol Toxicol; 2023 Oct; 39(5):1923-1937. PubMed ID: 35246762
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic composite hydrogel promotes new bone formation in rat bone defects through regulation of miR-19b-3p/WWP1 axis by loaded extracellular vesicles.
Guo R; Wu C; Liu F; Dong T; Zhang T
J Nanobiotechnology; 2023 Nov; 21(1):459. PubMed ID: 38037135
[TBL] [Abstract][Full Text] [Related]
9. Bone mesenchymal stem cell-derived extracellular vesicles promote the repair of intervertebral disc degeneration by transferring microRNA-199a.
Wen T; Wang H; Li Y; Lin Y; Zhao S; Liu J; Chen B
Cell Cycle; 2021 Feb; 20(3):256-270. PubMed ID: 33499725
[TBL] [Abstract][Full Text] [Related]
10. microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3.
Chang J; Li H; Zhu Z; Mei P; Hu W; Xiong X; Tao J
Cell Biol Toxicol; 2022 Aug; 38(4):577-590. PubMed ID: 33728488
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-derived extracellular vesicles suppress the fibroblast proliferation by downregulating FZD6 expression in fibroblasts via micrRNA-29b-3p in idiopathic pulmonary fibrosis.
Wan X; Chen S; Fang Y; Zuo W; Cui J; Xie S
J Cell Physiol; 2020 Nov; 235(11):8613-8625. PubMed ID: 32557673
[TBL] [Abstract][Full Text] [Related]
12. Hepatoma Cell-Derived Extracellular Vesicles Promote Liver Cancer Metastasis by Inducing the Differentiation of Bone Marrow Stem Cells Through microRNA-181d-5p and the FAK/Src Pathway.
Wei H; Wang J; Xu Z; Li W; Wu X; Zhuo C; Lu Y; Long X; Tang Q; Pu J
Front Cell Dev Biol; 2021; 9():607001. PubMed ID: 34124029
[TBL] [Abstract][Full Text] [Related]
13. microRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer.
Ding F; Liu J; Zhang X
Stem Cell Res Ther; 2020 Oct; 11(1):455. PubMed ID: 33109266
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis.
Zhou L; Shan Z; Fan J
Acta Haematol; 2023; 146(6):504-516. PubMed ID: 36327876
[TBL] [Abstract][Full Text] [Related]
15. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
[TBL] [Abstract][Full Text] [Related]
16. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
[TBL] [Abstract][Full Text] [Related]
17. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
18. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles carrying miR-193a derived from mesenchymal stem cells impede cell proliferation, migration and invasion of colon cancer by downregulating FAK.
Ying H; Lin F; Ding R; Wang W; Hong W
Exp Cell Res; 2020 Sep; 394(2):112144. PubMed ID: 32540398
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from bone marrow mesenchymal stem cells loaded on magnetic nanoparticles delay the progression of diabetic osteoporosis via delivery of miR-150-5p.
Xu C; Wang Z; Liu Y; Wei B; Liu X; Duan K; Zhou P; Xie Z; Wu M; Guan J
Cell Biol Toxicol; 2023 Aug; 39(4):1257-1274. PubMed ID: 36112264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
